🔥🐔 BizChicken 🐔🔥
Companies Similar to Foghorn Therapeutics Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CARGO Therapeutics, Inc. Common Stock
CRG-022
CARGO Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing chimeric antigen receptor (CAR) T-cell therapies for cancer patients. Their lead program, CRG-022, targets resistance mechanisms in B-cell malignancies.
About | Leadership | Directors | About | Contact | Contact | Careers | Careers | Careers | Careers | About | About
Symbol: CRGX
Recent Price: $13.76
Industry: Biotechnology
CEO: Ms. Gina Chapman
Sector: Healthcare
Employees: 150
Address: 1900 Alameda De Las Pulgas, San Mateo, null 94403
Phone: 650-379-6143
Leadership
- Gina Chapman, President and Chief Executive Officer
- Anup Radhakrishnan, Chief Financial Officer/Chief Business Officer
- Ginna Laport, MD, Chief Medical Officer
- Shishir Gadam, PhD, Chief Technical Officer
- Michael Ports, PhD, Chief Scientific Officer
- Kari Leetch, Chief People Officer
- Halley Gilbert, JD, Chief Legal Officer
- Bethany Rogers, SVP, Product Strategy and Commercialization
- Faisal Shawwa, SVP, Finance
- Tonia J. Buchholz, PhD, Head of Clinical Science
- Kanika Chawla, PhD, Head of Process Sciences
- Sandra Chen, Head of Clinical Quality and Risk Management
- Michelle Gray, Head of Clinical Operations
- Adam Haskett, Head of External Manufacturing
- David Hoffman, JD, Head of Intellectual Property & Transactions
- Anissa Irwin, Head of Quality Assurance and Systems
- Brett Masterson, Head of Marketing
- Rob McCombie, Head of CMC Regulatory
- Frank McDonald, Head of Clinical Data Management
- Priya Parameswaran, Head of Corporate Strategy and Business Operations
- Shabnum Patel, PHD, Head of MSAT
- Mary Rodley, Head of CMC Strategy and Operations
- Abhijeet Sarvaiya, Head of Statistical Programming
- Brian Schoelkopf, Head of FP&A
- Christophe Suchet, Head of IT
- Beth Vasievich, PhD, Head of Commercial Planning and Operations
- Jun Wang, Head of Procurement
- John Orwin, Chairman of the Board
- Abraham Bassan, Board Director
- Kapil Dhingra, M.B.B.S, Board Director
- Reid Huber, PHD, Board Director
- David Lubner, Board Director
- Krishnan Viswanadhan, Pharm.D, Board Director
- Jane Pritchett Henderson, Board Director
Last updated: 2024-12-31
Fate Therapeutics, Inc.
programmed cellular immunotherapies
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its development programs include various NK- and T-cell immuno-oncology therapies targeting different cancers.
Vision/Values | About | Management | Directors | About | Contact
Symbol: FATE
Recent Price: $1.62
Industry: Biotechnology
CEO: Mr. J. Scott Wolchko
Sector: Healthcare
Employees: 181
Address: 12278 Scripps Summit Drive, San Diego, CA 92131
Phone: 858 875 1800
Leadership
- William Rastetter, Ph.D., Chairman
- John Mendlein, Ph.D., J.D., Vice Chairman
- Dr. Shefali Agarwal, Board Member
- Timothy P. Coughlin, Board Member
- Robert S. Epstein, M.D., Board Member
- Karin Jooss, Ph.D., Board Member
- Michael Lee, Board Member
- Neely Mozaffarian, M.D., Ph.D., FACR, Board Member
- Yuan Xu, Ph.D., Board Member
- Scott Wolchko, President & CEO
Last updated: 2024-12-31
Mustang Bio, Inc.
Gene and CAR T Cell Therapies
Mustang Bio, Inc. is a biopharmaceutical company specializing in cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. It focuses on developing gene therapy programs and CAR T cell therapies, including treatments for X-linked severe combined immunodeficiency and various types of cancer.
About | Leadership | Directors | News | Contact | About | About | Careers | About | About | Careers | About | About
Symbol: MBIO
Recent Price: $0.19
Industry: Biotechnology
CEO: Dr. Manuel Litchman M.D.
Sector: Healthcare
Employees: 80
Address: 377 Plantation Street, Worcester, MA 01605
Phone: 781 652 4500
Leadership
- Manuel Litchman, M.D., President, Chief Executive Officer and Director
- Greg Furrow, M.S., FRQA, Chief Quality Officer
- James Murphy, B.A., Ad interim Chief Financial Officer
- Michael S. Weiss, Chairman of the Board of Directors
- Lindsay A. Rosenwald, M.D., Director
- Adam J. Chill, Director
- Neil Herskowitz, Director
- Michael J. Zelefsky, M.D., Director
- Mustang Bio, Inc., Company
Last updated: 2024-12-31
Precigen, Inc.
gene and cellular therapies
Precigen, Inc. is focused on discovering and developing advanced gene and cellular therapies, disease-modifying therapeutics, and genetic engineering technologies for regenerative medicine and other applications.
About | Contact | Careers | Careers | Careers | About | About | Benefits | Careers | About | About | About | Careers | Careers | About
Symbol: PGEN
Recent Price: $0.93
Industry: Biotechnology
CEO: Dr. Helen Sabzevari MPH, Ph.D.
Sector: Healthcare
Employees: 202
Address: 20374 Seneca Meadows Parkway, Germantown, MD 20876
Phone: 301 556 9900
Last updated: 2024-12-31
Sangamo Therapeutics, Inc.
ZFP Technology Platform
Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company that develops genomic medicines using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation with a focus on transforming patients' lives.
Contact | About | About | Leadership | Leadership | About | About | About | About | About | About | About | About | About | About | Careers | Vision/Values | DEI | Benefits | About | About | About | About | About | About | About | News | Events | Vision/Values | DEI | Benefits | Careers | Careers | About | About
Symbol: SGMO
Recent Price: $2.34
Industry: Biotechnology
CEO: Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Sector: Healthcare
Employees: 405
Address: 501 Canal Blvd, Brisbane California, CALIFORNIA 94005
Phone: 510 970 6000
Leadership
- Sandy Macrae, M.B., Ch.B., Ph.D.,
- Gregory Davis, Ph.D., Head of Research and Technology
- Nathalie Dubois-Stringfellow, Ph.D., Chief Development Officer
- Prathyusha Duraibabu, Chief Financial Officer
- Phillip Ramsey, Head of Technical Operations
- Stephanie J. Seiler, CLP, Head of Business Development & Alliance Management
- Louise Wilkie, Global Corporate Communications and Investor Relations
- Scott Willoughby, General Counsel and Corporate Secretary
- H. Stewart Parker, Chair of the Board
- Courtney Beers, Ph.D.,
- Robert Carey,
- Kenneth Hillan, M.B. Ch.B.,
- Margaret (Peg) A. Horn, J.D.,
- John Markels, Ph.D.,
- James R. Meyers,
- Karen Smith, M.D., Ph.D., M.B.A., LLM,
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Champions Oncology, Inc.
Tumorgraft Technology Platform
Champions Oncology, Inc. specializes in personalized cancer care technology solutions, including the Tumorgraft Technology Platform and Lumin Bioinformatics, aimed at enhancing oncology drug development and usage.
Symbol: CSBR
Recent Price: $8.62
Industry: Biotechnology
CEO: Dr. Ronnie Morris M.D.
Sector: Healthcare
Employees: 210
Address: One University Plaza, Hackensack, NJ 07601
Phone: 201 808 8400
Last updated: 2024-12-31
Foghorn Therapeutics Inc.
Gene Traffic Control platform
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. It utilizes its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system.
Symbol: FHTX
Recent Price: $4.61
Industry: Biotechnology
CEO: Mr. Adrian H. B. Gottschalk
Sector: Healthcare
Employees: 116
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 586 3100
Leadership
- Steven Bellon, PHD, Chief Scientific Officer
- Carlos Costa, Chief People Officer
- Danette Daniels, PHD, VP, Protein Degrader Platform
- Dan Dinu, MBA, VP, Information Technology
- Michael Garcia-Webb, PHD, VP, Chief of Staff Research
- Andrew Germain, PHD, VP, Legal
- Adrian Gottschalk, President & CEO
- Chong-Hui Gu, PHD, VP, CMC and QA
- Karin Hellsvik, Chief of Staff to the CEO Vice President, Corporate Affairs and Investor Relations
- Murphy Hentemann, PHD, VP, Program Leadership
- Kristian Humer, MBA, Chief Financial Officer
- Michael LaCascia, Chief Legal Officer
- Marina Nelen, PhD, VP, Drug Discovery
- Alfonso Quintás-Cardama, MD, Chief Medical Officer
- Alena Reva, VP, Total Rewards & People Operations
- Anna Rivkin, PHD, Chief Business Officer
- Saurabh Sewak, PHD, VP, Corporate Development
- Gromek Smolen, PHD, VP, Biology
- Kevin Wilson, PHD, VP, Chemistry
- José Baselga MD, PhD, In Memoriam
- Scott Biller, PHD, Strategic Advisor, Agios Pharmaceuticals
- Doug Cole, MD, Founder, Foghorn Therapeutics Managing Partner, Flagship Pioneering
- Simba Gill, PhD, Former President & CEO, Evelo Biosciences
- Cigall Kadoch, PhD, Scientific Advisor to the Board of Directors; Founder, Foghorn Therapeutics
- Adam Koppel, MD, PhD, Managing Director, Bain Capital Life Sciences
- Tom Lynch, MD, President and Director, Fred Hutchinson Cancer Center
- Michael Mendelsohn, MD, Chairman & Founder, Cardurion Pharmaceuticals
- Lynne Parshall, Senior Strategic Advisor, Ionis Pharmaceuticals
- Ian Smith, Chairman of the Board, Solid BioSciences
- Gerald Crabtree, MD, Founder, Foghorn Therapeutics David Korn Professor, Stanford University Medical School Investigator, Howard Hughes Medical Institute
- Tony Kouzarides, PhD, FMedSci, FRS, Professor of Cancer Biology at the University of Cambridge Director of the Milner Therapeutics Institute and Deputy Director of the Gurdon Institute
- Charles Sawyers, MD, Investigator, Howard Hughes Medical Institute Marie-Josée and Henry Kravis Chair in Human Oncology and Pathogenesis and Chairman, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center; SAB Chair
- David Schenkein, MD, General Partner, Co-leader, Google Ventures life science team Former CEO, Agios
Last updated: 2024-12-31
Gossamer Bio, Inc.
GB002, GB004, GB5121, GB7208
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.
About | About | Management | Directors | Contact | Locations | Contact | Contact | About | About
Symbol: GOSS
Recent Price: $0.88
Industry: Biotechnology
CEO: Mr. Faheem Hasnain
Sector: Healthcare
Employees: 135
Address: 3013 Science Park Road, San Diego, CA 92121
Phone: 858 684 1300
Leadership
- Faheem Hasnain, Chairman
- Richard Aranda, M.D., Chief Medical Officer
- Jeff Boerneke, General Counsel and Secretary
- Matt Cravets, Senior Vice President, Biometrics
- Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
- Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
- Caryn Peterson, Executive Vice President, Regulatory Affairs
- Bob Smith, Chief Commercial Officer
- Christian Waage, Executive Vice President, Technical Operations & Administration
- Deanna Weber, Senior Vice President, Human Resources
- Russell J. Cox, Director
- Thomas Daniel, Director
- Skye Drynan, Director
- Sandra Milligan, Director
- Steven D. Nathan, Director
- John Quisel, Director
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
Scopus BioPharma Inc.
Duet Platform
Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.
Symbol: SCPS
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Alan D. Horsager Ph.D.
Sector: Healthcare
Employees: 13
Address: 420 Lexington Avenue, New York, NY 10170
Phone: 212 479 2513
Last updated: 2024-12-31
Syros Pharmaceuticals, Inc.
Tamibarotene
Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases through gene control medicines. Key products include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, and SY-5609 for advanced solid tumors.
About | Leadership | Directors | About | Contact | Careers | Vision/Values | DEI | Careers | About | About
Symbol: SYRS
Recent Price: $0.25
Industry: Biotechnology
CEO: Mr. Conley Chee
Sector: Healthcare
Employees: 68
Address: 35 CambridgePark Drive, Cambridge, MA 02140
Phone: 617 744 1340
Leadership
- Conley Chee, President and Chief Executive Officer
- Jason Haas, Chief Financial Officer
- Gerald E. Quirk, Chief Legal & Compliance Officer; Chief Business Officer
- Lisa Roberts, VP Human Resources
- David A. Roth, M.D., Chief Medical Officer
- Kristin Stephens, Chief Development Officer
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Tevogen Bio Holdings Inc.
TVGN 489
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company developing off-the-shelf precision T cell therapeutics focusing on virology, oncology, and neurology, with a key focus on COVID-19 and long COVID treatments.
About | News | News | News | About | News | News | Contact | About | About | Careers | About | About | About | About | About | About | About
Symbol: TVGN
Recent Price: $1.05
Industry: Biotechnology
CEO: Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Sector: Healthcare
Employees: 17
Address: 15 Independence Blvd, Warren, NJ 07059
Phone: 877 838 6436
Last updated: 2024-12-31
10x Genomics, Inc.
chromium instruments
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems globally. Their products include chromium instruments and single cell solutions for gene expression and immune profiling.
About | Contact | Contact | Contact | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: TXG
Recent Price: $14.35
Industry: Medical - Healthcare Information Services
CEO: Dr. Serge Saxonov Ph.D.
Sector: Healthcare
Employees: 1259
Address: 6230 Stoneridge Mall Road, Pleasanton, CA 94588-3260
Phone: 925 401 7300
Last updated: 2024-12-31
Ginkgo Bioworks Holdings, Inc.
platform for cell programming
Ginkgo Bioworks Holdings, Inc. develops a platform used to program cells for biological production of products such as therapeutics, food ingredients, and chemicals. It serves markets in specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.
About | About | Contact | Contact | About | About | About | About | Vision/Values | About | About | About | Culture | About | Careers | About | About | About
Symbol: DNA
Recent Price: $9.44
Industry: Biotechnology
CEO: Dr. Jason Kelly
Sector: Healthcare
Employees: 1218
Address: 27 Drydock Avenue, Boston, MA 02210
Phone: 877 422 5362
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
Arcturus Therapeutics Holdings Inc.
RNA medicines
Arcturus Therapeutics Holdings Inc. focuses on developing vaccines for infectious and rare diseases, including programs for cystic fibrosis and ornithine transcarbamylase deficiency. The company collaborates with various partners for vaccine and therapeutic development.
Symbol: ARCT
Recent Price: $16.58
Industry: Biotechnology
CEO: Mr. Joseph E. Payne M.Sc.
Sector: Healthcare
Employees: 180
Address: 10628 Science Center Drive, San Diego, CA 92121
Phone: 858 900 2660
Last updated: 2024-12-31